Advanced Search

Technical Analysis for KYMR - Kymera Therapeutics, Inc.

Grade Last Price % Change Price Change
B 62.95 -3.00% -1.95
KYMR closed down 3.0 percent on Friday, September 17, 2021, on 5.5 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical KYMR trend table...
Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Hammer Candlestick Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Volume Surge Other 0.00%
Multiple of Ten Bullish Other 0.00%
Inside Day Range Contraction -3.00%
180 Bullish Setup Bullish Swing Setup -3.14%
Wide Bands Range Expansion -3.14%
New Uptrend Bullish -0.35%
Wide Bands Range Expansion -0.35%
Older End-of-Day Signals for KYMR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
20 DMA Support 1 day ago
Down 10% 1 day ago
Down 2 ATRs 1 day ago
60 Minute Opening Range Breakdown 1 day ago
2x Volume Pace 1 day ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators Basic chart:

Profile

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; and STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases. The company was founded in 2015 and is headquartered in Watertown, Massachusetts.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Immunology Solid Tumors Immune System Autoimmune Diseases Rheumatoid Arthritis Autoimmunity Hematologic Malignancies Dermatitis Atopic Dermatitis Hidradenitis Suppurativa

Is KYMR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Sep 17 The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
Sep 16 ABCL, TCRR, KYMR and GRTS among after hours movers
Sep 16 AbCellera, Kymera and Diamondback Move in After-Hours
Sep 2 Kymera Therapeutics to Present at Upcoming September Investor Conferences
Aug 8 Time To Worry? Analysts Are Downgrading Their Kymera Therapeutics, Inc. (NASDAQ:KYMR) Outlook
Aug 6 Kymera Therapeutics EPS misses by $0.26, misses on revenue
Aug 6 Kymera Therapeutics Announces Second Quarter 2021 Financial Results and Provides a Business Update
Jul 29 Kymera Therapeutics Appoints Karen Weisbach as Vice President, People and Culture and Jolly Bhatia as Vice President, Quality
Jul 28 Is KYMR Stock A Buy or Sell?
Jul 12 Kymera Therapeutics falls after posting pre-clinical data for lymphoma therapy
See more KYMR news...

Indicators

Indicator Value
52 Week High 91.92
52 Week Low 27.65
Average Volume 372,414
200-Day Moving Average 54.76
50-Day Moving Average 57.81
20-Day Moving Average 61.02
10-Day Moving Average 63.64
Average True Range 3.39
ADX 26.26
+DI 21.15
-DI 19.32
Chandelier Exit (Long, 3 ATRs) 57.42
Chandelier Exit (Short, 3 ATRs) 59.25
Upper Bollinger Bands 68.10
Lower Bollinger Band 53.94
Percent B (%b) 0.64
BandWidth 23.20
MACD Line 2.19
MACD Signal Line 2.08
MACD Histogram 0.1141
Fundamentals Value
Market Cap 2.8 Billion
Num Shares 44.5 Million
EPS
Price-to-Sales 88.83
Price-to-Book 6.96
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 71.96
Resistance 3 (R3) 71.37 67.79 70.46
Resistance 2 (R2) 67.79 65.49 68.08 69.96
Resistance 1 (R1) 65.37 64.08 63.58 65.95 69.46
Pivot Point 61.78 61.78 60.89 62.07 61.78
Support 1 (S1) 59.36 59.49 57.57 59.95 56.44
Support 2 (S2) 55.78 58.07 56.07 55.94
Support 3 (S3) 53.36 55.78 55.44
Support 4 (S4) 53.94